Randomized, double-blind, parallel group, placebo-controlled evaluation of the effectiveness of intravenous zoledronate for decreased periprosthetic bone resorption in patients with total knee prosthesis.["Ensayo clínico aleatorizado, doble ciego, de grupos paralelos, controlado con placebo para la valoración de la eficacia del zoledronato endovenoso para disminución de la resorción periprotésica en pacientes con protésis total de rodilla".]

Trial Profile

Randomized, double-blind, parallel group, placebo-controlled evaluation of the effectiveness of intravenous zoledronate for decreased periprosthetic bone resorption in patients with total knee prosthesis.["Ensayo clínico aleatorizado, doble ciego, de grupos paralelos, controlado con placebo para la valoración de la eficacia del zoledronato endovenoso para disminución de la resorción periprotésica en pacientes con protésis total de rodilla".]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2011

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Bone resorption
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top